Romy Celli’s practice focuses on patent prosecution, primarily in the area of biotechnology. Her practice includes advising clients in all areas of patent prosecution, including formulating and implementing global patent portfolio strategies for both first- and second-generation drug products and drug targets in more than 85 countries. Romy has experience in analyzing patents and advising clients concerning their validity, enforceability and infringement issues, performing freedom to operate analyses, conducting due diligence investigations, and deploying tactics to circumvent blocking patents, including opposition, interference, licensing and acquisition.
Romy was recognized as an Intellectual Property: Life Science Star practitioner by Managing Intellectual Property.
Romy earned her J.D. from Golden Gate University School of Law in 1997. She received her M.A. in 1990 in biomedical sciences, with an emphasis in biochemistry and molecular biology, and her A.B. in biological sciences in 1986 from the University of California, Berkeley. She is admitted to the U.S. Patent and Trademark Office, the California bar, and the U.S. Federal Courts for the Northern, Eastern Central and Southern Districts of California.
Alston & Bird has been recognized as a global leader in patent law in the 2015 edition of Intellectual Asset Management (IAM) Patent 1000 – The World’s Leading Patent Professionals, marking the fourth consecutive year that the firm has earned this recognition.
June 18, 2015
Alston & Bird’s various intellectual property groups have ranked highly in Intellectual Asset Management magazine’s recently released 2014 adjunct publication, IAM Patent 1000 – The World’s Leading Patent Professionals.
June 25, 2014
In the News
- Silicon Valley Intellectual Property Law Association
- American Intellectual Property Law Association (AIPLA)
- American Bar Association
- San Francisco Intellectual Property Law Association
- American Health Lawyers Association
- Los Angeles Intellectual Property Law Association